Kang et al. also proposed that interventions including the intermittent hypoxia conditioning and hyperbaric oxygen therapy to elevate the level of HIF-1 in the brain might be considered as new additional treatments for depression (Kang et al. 2021). The gene discussed is HIF1A; the disease is depressive disorder.